Infusion Of Cytomegalovirus Specific Cytotoxic T Lymphocytes From A Sero-Negative Donor Can Facilitate Resolution Of Infection And Immune Reconstitution

Pediatric Infectious Disease Journal

Volumn 28, Issue 1, 2009, Pages 65-67

  Horn, Biljana ^a   Bao, Lei ^b   Dunham, Kimberly ^b   Stamer, Mindy ^b   Adler, Stuart ^c   Cowan, Morton ^a   Lucas, Kenneth ^a,b  

^a PENN STATE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CMV; cytotoxic T cells; stem cell BMT; Vaccine

Indexed keywords

CIDOFOVIR; CYTOMEGALOVIRUS ANTIGEN PP65; CYTOMEGALOVIRUS VACCINE; FLUDARABINE; FOSCARNET; GANCICLOVIR; PEPTIDE DERIVATIVE; THIOTEPA; THYMOCYTE ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DRUG SUBSTITUTION; HUMAN; HUMAN CELL; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; MONOCYTE; NONHUMAN; PANCYTOPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; VIREMIA;

CELL CULTURE TECHNIQUES; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOMEGALOVIRUS VACCINES; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; PHOSPHOPROTEINS; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC; VIRAL MATRIX PROTEINS; YOUNG ADULT;

EID: 66149124774     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318182026f     Document Type: Article

References (13)

1. Nakamura R, Battiwalla M, Solomon S, et al. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant. 2004;10:49-57.
2. Bowden RA, Digel J, Reed EC, et al. Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses. J Infect Dis. 1987;156:899-903.
3. Battiwalla M, Wu Y, Bajwa RP, et al. Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis. Biol Blood Marrow Transplant. 2007;13:765-770.
4. Riddell SR, Watanabe KS, Goodrich JM, et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 1992;257:238-241.
5. Vannucchi AM, Glinz S, Bosi A, et al. Selective ex vivo expansion of cytomegalovirus-specific CD4- and CD8- T lymphocytes using dendritic cells pulsed with a human leucocyte antigen A*0201-restricted peptide. Br J Haematol. 2001;113:479-482.
6. Einsele H, Roosnek E, Rufer N, et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood. 2002;99:3916-3922.
7. Sun Q, Burton RL, Dai LJ, et al. B lymphoblastoid cell lines as efficient APC to elicit CD8- T cell responses against a cytomegalovirus antigen. J Immunol. 2000;165:4105-4111.
8. Bao L, Sun Q, Lucas KG. Rapid generation of CMV pp65-specific T cells for immunotherapy. J Immunother. 2007;30:557-561.
9. Jacobson MA, Sinclair E, Bredt B, et al. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-sero-negative vaccine recipients. J Clin Virol. 2006;35:332-337.
10. Sylwester AW, Mitchell BL, Edgar JB, et al. Broadly targeted human cytomegalovirus-specific CD4- and CD8- T cells dominate the memory compartments of exposed subjects. J Exp Med. 2005;202:673-685.
11. Zaia JA, Forman SJ, Ting YP, et al. Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients. J Infect Dis. 1986;153:780-787.
12. Bitmansour AD, Waldrop SL, Pitcher CJ, et al. Clonotypic structure of the human CD4- memory T cell response to cytomegalovirus. J Immunol. 2001;167:1151-1163.
13. Wills MR, Carmichael AJ, Mynard K, et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol. 1996;70:7569-7579.